Chemoinformaics analysis of (20s)-3beta-30-dihydroxylupane
| Molecular Weight | 444.744 | nRot | 1 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 25 |
| Exact Molecular Weight | 444.397 | nRing | 5 |
| Solubility: LogS | -4.884 | nHRing | 0 |
| Solubility: LogP | 6.553 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 86.3772 |
| nHD | 2 | BPOL | 52.1668 |
| QED | 0.448 |
| Synth | 4.747 |
| Natural Product Likeliness | 2.96 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.041 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -5.092 |
| MDCK | 0.000024 |
| BBB | 0.029 |
| PPB | 0.943215 |
| VDSS | 1.133 |
| FU | 0.0158457 |
| CYP1A2-inh | 0.034 |
| CYP1A2-sub | 0.488 |
| CYP2c19-inh | 0.071 |
| CYP2c19-sub | 0.944 |
| CYP2c9-inh | 0.114 |
| CYP2c9-sub | 0.584 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.59 |
| CYP3a4-inh | 0.188 |
| CYP3a4-sub | 0.326 |
| CL | 3.866 |
| T12 | 0.147 |
| hERG | 0.09 |
| Ames | 0.001 |
| ROA | 0.102 |
| SkinSen | 0.727 |
| Carcinogencity | 0.003 |
| EI | 0.856 |
| Respiratory | 0.87 |
| NR-Aromatase | 0.027 |
| Antiviral | No |
| Prediction | 0.9003 |